401 drugs approved in multiple markets
| Generic Name (INN) | Markets | PMDA | FDA | |
|---|---|---|---|---|
Paclitaxel Abraxane, パクリタキセル注30 mg/5 ｍL「NK」, アブラキサン点滴静注用100 mg ... | PMDA (EN)PMDA (JP) | 2019 | — | |
Antithrombin gamma (genetical recombination) Acoalan, アコアラン静注用600 | PMDA (EN)PMDA (JP) | 2015 | — | |
Tocilizumab (genetical recombination) Actemra, ①トシリズマブBS点滴静注80 mg「CT」, ①トシリズマブBS点滴静注80 mg「MA」 ... | PMDA (EN)PMDA (JP) | 2022 | — | |
Riociguat Adempas, アデムパス錠0.5mg | PMDA (EN)PMDA (JP) | 2014 | — | |
Anamorelin hydrochloride Adlumiz, エドルミズ錠50 mg | PMDA (EN)PMDA (JP) | 2021 | — | |
Lonoctocog alfa (genetical recombination) Afstyla, エイフスチラ静注用250 | PMDA (EN)PMDA (JP) | 2017 | — | |
Sotatercept (genetical recombination) Airwin, エアウィン皮下注用45 mg | PMDA (EN)PMDA (JP) | 2025 | — | |
Aminolevulinic acid hydrochloride Alabel/Alaglio, アラグリオ顆粒剤分包1.5 g, アラグリオ顆粒剤分包1.5g ... | PMDA (EN)PMDA (JP) | 2013 | — | |
Alectinib hydrochloride Alecensa, アレセンサカプセル150 mg, アレセンサカプセル20mg ... | PMDA (EN)PMDA (JP) | 2014 | — | |
Concizumab (genetical recombination) Alhemo, アレモ皮下注15 mg | PMDA (EN)PMDA (JP) | 2023 | — | |
Amenamevir Amenalief, アメナリーフ錠200 mg, アメナリーフ錠200mg | PMDA (EN)PMDA (JP) | 2017 | — | |
Garadacimab (genetical recombination) Andembry, アナエブリ皮下注200 mgペン | PMDA (EN)PMDA (JP) | 2025 | — | |
Carvedilol Artist, COREG, アーチスト錠2.5 mg | PMDA (EN)FDA (US)PMDA (JP) | 2015 | 1995 | |
Repotrectinib Augtyro, AUGTYRO, オータイロカプセル40 mg ... | PMDA (EN)FDA (US)PMDA (JP) | 2024 | 2023 | |
Bevacizumab (genetical recombination) Avastin, AVASTIN, ベバシズマブBS点滴静注100 mg「CTNK」 ... | PMDA (EN)FDA (US)PMDA (JP) | 2016 | 2004 | |
Favipiravir Avigan, アビガン錠200 mg, アビガン錠200mg | PMDA (EN)PMDA (JP) | 2014 | — | |
Insulin icodec (genetical recombination) Awiqli, アウィクリ注 フレックスタッチ 総量300単位 | PMDA (EN)PMDA (JP) | 2024 | — | |
Avelumab (genetical recombination) Bavencio, バベンチオ点滴静注200 mg, バベンチオ点滴静注200mg ... | PMDA (EN)PMDA (JP) | 2017 | — | |
Belimumab (genetical recombination) Benlysta, ベンリスタ皮下注200 mgオートインジェクター, ベンリスタ点滴静注用120 mg ... | PMDA (EN)PMDA (JP) | 2019 | — | |
Inotuzumab ozogamicin (genetical recombination) Besponsa, ベスポンサ点滴静注用1 mg, ベスポンサ点滴静注用1mg | PMDA (EN)PMDA (JP) | 2024 | — |
Showing 20 of 401 cross-reference groups
Upgrade to access the full cross-reference database.
View Plans